VisCardia’s implantable VisOne diaphragm stimulator
Novel heart failure device developer VisCardia, Inc. (Portland, Ore.) announced the first implant of the VisONE system for heart failure and the launch of the system’s heart failure pilot study in Ukraine.
The VisONE implantable system delivers asymptomatic diaphragmatic stimulation (ADS) therapy to improve cardiac function. A surgeon laparoscopically implants a medical device equipped with electrodes to deliver electrical pulses to precise areas of the diaphragm. The electrically stimulated diaphragm applies transient intrathoracic pressures gaited to cardiac activity against the cardiac walls, improving both cardiac filling and output, according to the company.
Get the full story on our sister site, Medical Design & Outsourcing.
The post VisCardia heart failure implant study underway in Ukraine appeared first on MassDevice.
from MassDevice https://ift.tt/2OCtHpi
Cap comentari:
Publica un comentari a l'entrada